Recombinant multi-species ADAMTS10 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ADAMTS10 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene belongs to the ADAMTS (a disintegrin and metalloproteinase domain with thrombospondin type-1 motifs) family of zinc-dependent proteases. ADAMTS proteases are complex secreted enzymes containing a prometalloprotease domain of the reprolysin type attached to an ancillary domain with a highly conserved structure that includes at least one thrombospondin type 1 repeat. They have been demonstrated to have important roles in connective tissue organization, coagulation, inflammation, arthritis, angiogenesis and cell migration. The product of this gene plays a major role in growth and in skin, lens, and heart development. It is also a candidate gene for autosomal recessive Weill-Marchesani syndrome. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 9430006O18,A disintegrin and metalloproteinase with thrombospondin motifs 10,ADAM-TS 10,ADAM-TS10,ADAMTS-10,ADAMTS10,Adam-ts10,Adamts-10,Adamts10,WMS,WMS1,Znmp

Target products collectionGo to ADAMTS10 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0638-Ag-1/ GM-Tg-hg-SE0638-Ag-2 Human ADAMTS10 protein Human
GM-Tg-rg-SE0638-Ag-1/ GM-Tg-rg-SE0638-Ag-2 Rat ADAMTS10 protein Rat
GM-Tg-mg-SE0638-Ag-1/ GM-Tg-mg-SE0638-Ag-2 Mouse ADAMTS10 protein Mouse
GM-Tg-cynog-SE0638-Ag-1/ GM-Tg-cynog-SE0638-Ag-2 Cynomolgus/Rhesus macaque ADAMTS10 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0638-Ag-1/ GM-Tg-felg-SE0638-Ag-2 Feline ADAMTS10 protein Feline
GM-Tg-cang-SE0638-Ag-1/ GM-Tg-cang-SE0638-Ag-2 Canine ADAMTS10 protein Canine
GM-Tg-bovg-SE0638-Ag-1/ GM-Tg-bovg-SE0638-Ag-2 Bovine ADAMTS10 protein Bovine
GM-Tg-equg-SE0638-Ag-1/ GM-Tg-equg-SE0638-Ag-2 Equine ADAMTS10 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0638-Ag-1/ GM-Tg-hg-SE0638-Ag-2; GM-Tg-rg-SE0638-Ag-1/ GM-Tg-rg-SE0638-Ag-2;
GM-Tg-mg-SE0638-Ag-1/ GM-Tg-mg-SE0638-Ag-2; GM-Tg-cynog-SE0638-Ag-1/ GM-Tg-cynog-SE0638-Ag-2;
GM-Tg-felg-SE0638-Ag-1/ GM-Tg-felg-SE0638-Ag-2; GM-Tg-cang-SE0638-Ag-1/ GM-Tg-cang-SE0638-Ag-2;
GM-Tg-bovg-SE0638-Ag-1/ GM-Tg-bovg-SE0638-Ag-2; GM-Tg-equg-SE0638-Ag-1/ GM-Tg-equg-SE0638-Ag-2
Products Name ADAMTS10 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ADAMTS10
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ADAMTS10 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.